BTI - British American Tobacco p.l.c.
NYSE
->
Consumer Defensive
->
Tobacco
London,
United Kingdom
Type: Equity
BTI price evolution
BTI
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $3737 | $3793 | $4379 | $4516 |
| Inventory | $5334 | $4938 | $5634 | $5671 |
| Total current assets | $15872 | $14186 | $15092 | $15409 |
| Long term investments | ||||
| Property, plant & equipment | $4427 | $4583 | $4521 | $4867 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $119369 | $118716 | $146072 | $153546 |
| Current liabilities | ||||
| Accounts payable | $9017 | $9700 | $9217 | $10449 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $18042 | $15673 | $16191 | $17853 |
| Long term debt | $32852 | $35406 | $37140 | $38726 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $65258 | $66150 | $73774 | $78178 |
| Shareholders' equity | ||||
| Retained earnings | $25178 | $23637 | $43870 | $46736 |
| Other shareholder equity | $1685 | $1685 | $1185 | $1390 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3247 | $3116 | $2809 | $4030.48 |
| Short term investments | $187.8 | $423.71 | $242 | |
| Net receivables | $3793 | $4516 | $4068 | $3792 |
| Inventory | $4938 | $5671 | $5279 | $5986 |
| Total current assets | $14186 | $15409 | $12807 | $13584 |
| Long term investments | $108459.44 | $136117.71 | $1998 | $2181 |
| Property, plant & equipment | $4583 | $4867 | $4953 | $5050 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $159316.1 | |||
| Total investments | ||||
| Total assets | $118716 | $153546 | $137365 | $137408 |
| Current liabilities | ||||
| Accounts payable | $9700 | $10449 | $3923 | $3714 |
| Deferred revenue | ||||
| Short long term debt | $4486.55 | $4348.49 | $3520 | $3535 |
| Total current liabilities | $15673 | $17853 | $15144 | $15446 |
| Long term debt | $35406 | $38726 | $35346 | $39845 |
| Total noncurrent liabilities | $76085.99 | |||
| Total debt | ||||
| Total liabilities | $66150 | $78178 | $69964 | $74582 |
| Shareholders' equity | ||||
| Retained earnings | $58715 | $46736 | $49334 | $73454 |
| Other shareholder equity | $21 | $1390 | $22168 | -$6196 |
| Total shareholder equity | $52793.69 | $72605.9 | $67101 | $62545 |
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $13441 | $14786 | ||
| Cost of revenue | ||||
| Gross Profit | $11197 | $12385 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $5261 | $5422 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $1268 | $1355 | ||
| Interest expense | -$632 | -$582 | ||
| Net income | ||||
| Net income | $3959 | $4807 | ||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 2 Mar 2023 | 30 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $27283 | $27250.74 | $25684 | $25707 |
| Cost of revenue | $4711.11 | $4597 | $7628 | |
| Gross Profit | $22392 | $22539.63 | $21087 | $18079 |
| Operating activities | ||||
| Research & development | $121 | |||
| Selling, general & administrative | $3808 | $6815 | ||
| Total operating expenses | $9777 | $17811.76 | $14684 | $14421.18 |
| Operating income | $9438.97 | $11000 | $9352 | |
| Income from continuing operations | ||||
| EBIT | $10585.96 | $11000 | $22662 | |
| Income tax expense | -$2872 | $2441.78 | $2189 | $2104 |
| Interest expense | -$1370 | -$1504 | $1651 | |
| Net income | ||||
| Net income | -$14367 | $6568.56 | $6801 | $6551 |
| Income (for common shares) | $6568.56 | $6789 | $6551 | |
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $1433 | -$296 | $41 | -$705 |
| Financing activities | ||||
| Dividends paid | -$2605 | -$5055 | -$2479 | -$4915 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$3358 | -$9314 | -$3023 | -$8878 |
| Effect of exchange rate | -$63 | -$292 | -$171 | $431 |
| Change in cash and equivalents | $1177 | $1180 | $226 | $874 |
| (in millions $) | 31 Jan 2024 | 2 Mar 2023 | 30 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $6568.56 | $6801 | $6387 | |
| Operating activities | ||||
| Depreciation | $1285.92 | $938 | $832 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $10242.06 | $9717 | $8080 | |
| Investing activities | ||||
| Capital expenditures | -$646.41 | -$527 | -$438 | |
| Investments | -$361 | -$113 | ||
| Total cash flows from investing | -$296 | -$694.69 | -$1140 | -$812 |
| Financing activities | ||||
| Dividends paid | -$5055 | -$4910 | -$4735 | |
| Sale and purchase of stock | -$17 | |||
| Net borrowings | $39778.89 | -$4019 | -$805 | |
| Total cash flows from financing | -$9314 | -$8748.22 | -$8749 | -$6164 |
| Effect of exchange rate | -$292 | -$253 | -$237 | |
| Change in cash and equivalents | $1180 | $1306.82 | -$425 | $851 |
News
Fundamentals
| Market cap | $115.54B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 2.20B |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.25 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.88 |
| Quick ratio | 0.58 |